Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ann decrease » nn decrease (Expand Search), gain decreased (Expand Search), mean decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
100 fold » 10 fold (Expand Search), 20 fold (Expand Search)
_ ann » _ any (Expand Search), _ ant (Expand Search), _ anc (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ann decrease » nn decrease (Expand Search), gain decreased (Expand Search), mean decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
100 fold » 10 fold (Expand Search), 20 fold (Expand Search)
_ ann » _ any (Expand Search), _ ant (Expand Search), _ anc (Expand Search)
-
1
-
2
-
3
-
4
-
5
HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching.
Published 2015“…[NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”
-
6
-
7
-
8
WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription.
Published 2013“…<p>(<i>A</i>) WNT3 decreased proliferation of GCPs by 40.3± 5.0% of the control (Con) (n=3) as measured by [<sup>3</sup>H]-Thymidine incorporation assay. …”
-
9
-
10
-
11
-
12
Genes whose expression was decreased by 100 nM ouabain by more than 1.3-fold.
Published 2019“…<p>Genes whose expression was decreased by 100 nM ouabain by more than 1.3-fold.</p>…”
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20